France · 
What does Transgene invest in?
Transgene invests most often at Series A (100% of the rounds on record), in sectors such as Biotechnology, Manufacturing and Pharmaceutical.
Transgene highlights
- 01
1 rounds on record
- 02
Mostly Series A: 100% of its rounds
What they do
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- BiotechnologyManufacturingPharmaceutical
- Based in
- Illkirch-Graffenstaden, France
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first1 appearances
- 2013
1 round
- May
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
What they claim to have backed
From their own portfolio page (on their website)
0 of 10 we have independently watched raise
A viral-based individualizedClinicaltrialsCslideEuclinicaltrialsExpanded AccessFrench National CancerUS National Cancer InstituteViral-based individualized neoantigenWCIDWebtoffee
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.